Inventor · disambiguated record
Mark Kastantin
Also filed as: KASTANTIN MARK · KASTANTIN MARK JOSEPH
2 granted patents·6 pending applications·1 citations·filing 2010–2025
32Inventor score
Top patents by PatentIndex Score
8 records- 0170US11426403B2Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using sameST IP HOLDING AG·Filed 2019·Granted Aug 30, 2022·1 cites·19 claims
- 0256US11185544B2Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using sameST IP HOLDING AG·Filed 2019·Granted Nov 30, 2021·0 cites·23 claims
- 0356US2025177287A1Methods and systems for injectable formulationsSERAN BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0455US2022296589A1Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using SameST IP HOLDING AG·Filed 2021·Application pending·0 cites
- 0552US2024181412A1Methods and systems for spray drying temperature sensitive productsSERAN BIOSCIENCE LLC·Filed 2023·Application pending·0 cites
- 0651US2024009128A1Methods and systems for use of low-volatility solvents for spray dryingSERAN BIOSCIENCE LLC·Filed 2023·Application pending·0 cites
- 0736US2025235398A1High dosage injectable bevacizumab formulations and methodsSERAN BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 0835US2011081293A1Methods and compositions related to clot-binding lipid compoundsSANFORD BURNHAM MED RES INST·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Kastantin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →